Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by HAVN Life Sciences Inc.

HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
From HAVN Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
From Havn Life Sciences Inc.
Via AccessWire
Exposures Product Safety
Tickers CSE:HAVN HAVLF
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
From Havn Life Sciences Inc.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Tickers CSE:HAVN HAVLF
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
From Havn Life Sciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Tickers CSE:HAVN HAVLF
HAVN Life Natural Health Products Now Available on Amazon.ca
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health
From Havn Life Sciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Tickers CSE:HAVN HAVLF
HAVN Life Announces Retail Partnership with Grocer, Choices Markets
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Launches New Line of Natural Health Products
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
From Havn Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:HAVN HAVLF
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
From Havn Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:HAVN HAVLF
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
From Havn Life Sciences Inc.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Tickers CSE:HAVN HAVLF
Havn Life Develops New Method for Rapid Psilocybin Testing
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
Havn Labs Jamaica Facility Now Fully Operational
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
From Havn Life Sciences Inc.
Via AccessWire
Tickers CSE:HAVN HAVLF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.